Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Non-obese women with hair loss have higher heart disease risk.

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.

Hair loss in women not always linked to increased oil production; other factors may be involved.